(en) Sarah L. Hardoon, Peter H. Whincup, Lucy T. Lennon, S. Goya Wannamethee, Simon Capewell et Richard W. Morris, « How Much of the Recent Decline in the Incidence of Myocardial Infarction in British Men Can Be Explained by Changes in Cardiovascular Risk Factors?: Evidence From a Prospective Population-Based Study », Circulation, vol. 117, no 5, , p. 598–604 (ISSN0009-7322 et 1524-4539, PMID18212284, PMCIDPMC3194091, DOI10.1161/CIRCULATIONAHA.107.705947, lire en ligne, consulté le ).
(en) Cindy L. Grineset al., « A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction », New England Journal of Medicine, vol. 328, no 10, , p. 673–679 (ISSN0028-4793 et 1533-4406, DOI10.1056/NEJM199303113281001, lire en ligne, consulté le ).
(en) Marc A. Pfefferet al., « Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial », New England Journal of Medicine, vol. 327, no 10, , p. 669–677 (ISSN0028-4793 et 1533-4406, DOI10.1056/NEJM199209033271001, lire en ligne, consulté le ).
(en) Sarah L. Hardoon, Peter H. Whincup, Lucy T. Lennon, S. Goya Wannamethee, Simon Capewell et Richard W. Morris, « How Much of the Recent Decline in the Incidence of Myocardial Infarction in British Men Can Be Explained by Changes in Cardiovascular Risk Factors?: Evidence From a Prospective Population-Based Study », Circulation, vol. 117, no 5, , p. 598–604 (ISSN0009-7322 et 1524-4539, PMID18212284, PMCIDPMC3194091, DOI10.1161/CIRCULATIONAHA.107.705947, lire en ligne, consulté le ).
(en) David D. McManus, Joel Gore, Jorge Yarzebski, Frederick Spencer, Darleen Lessard et Robert J. Goldberg, « Recent Trends in the Incidence, Treatment, and Outcomes of Patients with STEMI and NSTEMI », The American Journal of Medicine, vol. 124, no 1, , p. 40–47 (PMID21187184, PMCIDPMC3011975, DOI10.1016/j.amjmed.2010.07.023, lire en ligne, consulté le ).
(en) Kivimäki M, Nyberg ST, Batty GD, Fransson EI, Theorell T et al. IPD-Work Consortium, « Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data », Lancet, vol. 380, no 9852, , p. 1491-7. (PMID22981903, PMCIDPMC3486012, DOI10.1016/S0140-6736(12)60994-5., lire en ligne [html])modifier
(en) Ford ES, Caspersen CJ, « Sedentary behaviour and cardiovascular disease: a review of prospective studies », Int J Epidemiol, vol. 41, no 5, , p. 1338-53. (PMID22634869, DOI10.1093/ije/dys078, lire en ligne [html])modifier
(en) Scott A Lear, Weihong Hu, Sumathy Rangarajan et Danijela Gasevic, « The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study », The Lancet, vol. 390, no 10113, , p. 2643–2654 (ISSN0140-6736, DOI10.1016/s0140-6736(17)31634-3, lire en ligne, consulté le )
(en) J Michael Gaziano, Carlos Brotons, Rosa Coppolecchia et Claudio Cricelli, « Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial », The Lancet, vol. 392, no 10152, , p. 1036–1046 (ISSN0140-6736, DOI10.1016/s0140-6736(18)31924-x, lire en ligne, consulté le )
(en) Lars Wallentin, Richard C. Becker, Andrzej Budaj et Christopher P. Cannon, « Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes », New England Journal of Medicine, vol. 361, no 11, , p. 1045–1057 (ISSN0028-4793 et 1533-4406, DOI10.1056/NEJMoa0904327, lire en ligne, consulté le )
(en) Stephen D. Wiviott, Eugene Braunwald, Carolyn H. McCabe et Gilles Montalescot, « Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes », New England Journal of Medicine, vol. 357, no 20, , p. 2001–2015 (ISSN0028-4793 et 1533-4406, DOI10.1056/NEJMoa0706482, lire en ligne, consulté le )
(en) Sanam Safi, Naqash J. Sethi, Steven Kwasi Korang et Emil Eik Nielsen, « Beta-blockers in patients without heart failure after myocardial infarction », The Cochrane Database of Systematic Reviews, vol. 11, no 11, , p. CD012565 (ISSN1469-493X, PMID34739733, PMCID8570410, DOI10.1002/14651858.CD012565.pub2, lire en ligne, consulté le )
(en) Kamalita Pertiwi, Leanne K. Küpers, Janette de Goede et Peter L. Zock, « Dietary and Circulating Long-Chain Omega-3 Polyunsaturated Fatty Acids and Mortality Risk After Myocardial Infarction: A Long-Term Follow-Up of the Alpha Omega Cohort », Journal of the American Heart Association, vol. 10, no 23, , e022617 (ISSN2047-9980, PMID34845924, PMCID9075367, DOI10.1161/JAHA.121.022617, lire en ligne, consulté le )
elsevier.com
linkinghub.elsevier.com
(en) David D. McManus, Joel Gore, Jorge Yarzebski, Frederick Spencer, Darleen Lessard et Robert J. Goldberg, « Recent Trends in the Incidence, Treatment, and Outcomes of Patients with STEMI and NSTEMI », The American Journal of Medicine, vol. 124, no 1, , p. 40–47 (PMID21187184, PMCIDPMC3011975, DOI10.1016/j.amjmed.2010.07.023, lire en ligne, consulté le ).
(en) E. I. Chazov, L. S. Matveeva, A. V. Mazaev, K. E. Sargin, G. V. Sadovskaia et M. I. Ruda, « Intracoronary administration of fibrinolysin in acute myocardial infarct », Terapevticheskii Arkhiv, vol. 48, no 4, , p. 8–19 (ISSN0040-3660, PMID136054).
(en) « Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) », Lancet (London, England), vol. 1, no 8478, , p. 397–402 (ISSN0140-6736, PMID2868337).
« Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group », Lancet (London, England), vol. 2, no 8607, , p. 349–360 (ISSN0140-6736, PMID2899772).
(en) Cindy L. Grineset al., « A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction », New England Journal of Medicine, vol. 328, no 10, , p. 673–679 (ISSN0028-4793 et 1533-4406, DOI10.1056/NEJM199303113281001, lire en ligne, consulté le ).
(en) Marc A. Pfefferet al., « Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial », New England Journal of Medicine, vol. 327, no 10, , p. 669–677 (ISSN0028-4793 et 1533-4406, DOI10.1056/NEJM199209033271001, lire en ligne, consulté le ).
(en) Sarah L. Hardoon, Peter H. Whincup, Lucy T. Lennon, S. Goya Wannamethee, Simon Capewell et Richard W. Morris, « How Much of the Recent Decline in the Incidence of Myocardial Infarction in British Men Can Be Explained by Changes in Cardiovascular Risk Factors?: Evidence From a Prospective Population-Based Study », Circulation, vol. 117, no 5, , p. 598–604 (ISSN0009-7322 et 1524-4539, PMID18212284, PMCIDPMC3194091, DOI10.1161/CIRCULATIONAHA.107.705947, lire en ligne, consulté le ).
(en) Scott A Lear, Weihong Hu, Sumathy Rangarajan et Danijela Gasevic, « The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study », The Lancet, vol. 390, no 10113, , p. 2643–2654 (ISSN0140-6736, DOI10.1016/s0140-6736(17)31634-3, lire en ligne, consulté le )
(en) J Michael Gaziano, Carlos Brotons, Rosa Coppolecchia et Claudio Cricelli, « Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial », The Lancet, vol. 392, no 10152, , p. 1036–1046 (ISSN0140-6736, DOI10.1016/s0140-6736(18)31924-x, lire en ligne, consulté le )
(en) Lars Wallentin, Richard C. Becker, Andrzej Budaj et Christopher P. Cannon, « Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes », New England Journal of Medicine, vol. 361, no 11, , p. 1045–1057 (ISSN0028-4793 et 1533-4406, DOI10.1056/NEJMoa0904327, lire en ligne, consulté le )
(en) Stephen D. Wiviott, Eugene Braunwald, Carolyn H. McCabe et Gilles Montalescot, « Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes », New England Journal of Medicine, vol. 357, no 20, , p. 2001–2015 (ISSN0028-4793 et 1533-4406, DOI10.1056/NEJMoa0706482, lire en ligne, consulté le )
(en) Sanam Safi, Naqash J. Sethi, Steven Kwasi Korang et Emil Eik Nielsen, « Beta-blockers in patients without heart failure after myocardial infarction », The Cochrane Database of Systematic Reviews, vol. 11, no 11, , p. CD012565 (ISSN1469-493X, PMID34739733, PMCID8570410, DOI10.1002/14651858.CD012565.pub2, lire en ligne, consulté le )
(en) Kamalita Pertiwi, Leanne K. Küpers, Janette de Goede et Peter L. Zock, « Dietary and Circulating Long-Chain Omega-3 Polyunsaturated Fatty Acids and Mortality Risk After Myocardial Infarction: A Long-Term Follow-Up of the Alpha Omega Cohort », Journal of the American Heart Association, vol. 10, no 23, , e022617 (ISSN2047-9980, PMID34845924, PMCID9075367, DOI10.1161/JAHA.121.022617, lire en ligne, consulté le )
nejm.org
nejm.org
(en) Cindy L. Grineset al., « A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction », New England Journal of Medicine, vol. 328, no 10, , p. 673–679 (ISSN0028-4793 et 1533-4406, DOI10.1056/NEJM199303113281001, lire en ligne, consulté le ).
(en) Marc A. Pfefferet al., « Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial », New England Journal of Medicine, vol. 327, no 10, , p. 669–677 (ISSN0028-4793 et 1533-4406, DOI10.1056/NEJM199209033271001, lire en ligne, consulté le ).
(en) Lars Wallentin, Richard C. Becker, Andrzej Budaj et Christopher P. Cannon, « Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes », New England Journal of Medicine, vol. 361, no 11, , p. 1045–1057 (ISSN0028-4793 et 1533-4406, DOI10.1056/NEJMoa0904327, lire en ligne, consulté le )
(en) Stephen D. Wiviott, Eugene Braunwald, Carolyn H. McCabe et Gilles Montalescot, « Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes », New England Journal of Medicine, vol. 357, no 20, , p. 2001–2015 (ISSN0028-4793 et 1533-4406, DOI10.1056/NEJMoa0706482, lire en ligne, consulté le )
(en) E. I. Chazov, L. S. Matveeva, A. V. Mazaev, K. E. Sargin, G. V. Sadovskaia et M. I. Ruda, « Intracoronary administration of fibrinolysin in acute myocardial infarct », Terapevticheskii Arkhiv, vol. 48, no 4, , p. 8–19 (ISSN0040-3660, PMID136054).
(en) « Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) », Lancet (London, England), vol. 1, no 8478, , p. 397–402 (ISSN0140-6736, PMID2868337).
« Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group », Lancet (London, England), vol. 2, no 8607, , p. 349–360 (ISSN0140-6736, PMID2899772).
(en) Sarah L. Hardoon, Peter H. Whincup, Lucy T. Lennon, S. Goya Wannamethee, Simon Capewell et Richard W. Morris, « How Much of the Recent Decline in the Incidence of Myocardial Infarction in British Men Can Be Explained by Changes in Cardiovascular Risk Factors?: Evidence From a Prospective Population-Based Study », Circulation, vol. 117, no 5, , p. 598–604 (ISSN0009-7322 et 1524-4539, PMID18212284, PMCIDPMC3194091, DOI10.1161/CIRCULATIONAHA.107.705947, lire en ligne, consulté le ).
(en) David D. McManus, Joel Gore, Jorge Yarzebski, Frederick Spencer, Darleen Lessard et Robert J. Goldberg, « Recent Trends in the Incidence, Treatment, and Outcomes of Patients with STEMI and NSTEMI », The American Journal of Medicine, vol. 124, no 1, , p. 40–47 (PMID21187184, PMCIDPMC3011975, DOI10.1016/j.amjmed.2010.07.023, lire en ligne, consulté le ).
(en) Kivimäki M, Nyberg ST, Batty GD, Fransson EI, Theorell T et al. IPD-Work Consortium, « Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data », Lancet, vol. 380, no 9852, , p. 1491-7. (PMID22981903, PMCIDPMC3486012, DOI10.1016/S0140-6736(12)60994-5., lire en ligne [html])modifier
(en) Ford ES, Caspersen CJ, « Sedentary behaviour and cardiovascular disease: a review of prospective studies », Int J Epidemiol, vol. 41, no 5, , p. 1338-53. (PMID22634869, DOI10.1093/ije/dys078, lire en ligne [html])modifier
(en) Sanam Safi, Naqash J. Sethi, Steven Kwasi Korang et Emil Eik Nielsen, « Beta-blockers in patients without heart failure after myocardial infarction », The Cochrane Database of Systematic Reviews, vol. 11, no 11, , p. CD012565 (ISSN1469-493X, PMID34739733, PMCID8570410, DOI10.1002/14651858.CD012565.pub2, lire en ligne, consulté le )
(en) Kamalita Pertiwi, Leanne K. Küpers, Janette de Goede et Peter L. Zock, « Dietary and Circulating Long-Chain Omega-3 Polyunsaturated Fatty Acids and Mortality Risk After Myocardial Infarction: A Long-Term Follow-Up of the Alpha Omega Cohort », Journal of the American Heart Association, vol. 10, no 23, , e022617 (ISSN2047-9980, PMID34845924, PMCID9075367, DOI10.1161/JAHA.121.022617, lire en ligne, consulté le )
pubmed.ncbi.nlm.nih.gov
(en) Sanam Safi, Naqash J. Sethi, Steven Kwasi Korang et Emil Eik Nielsen, « Beta-blockers in patients without heart failure after myocardial infarction », The Cochrane Database of Systematic Reviews, vol. 11, no 11, , p. CD012565 (ISSN1469-493X, PMID34739733, PMCID8570410, DOI10.1002/14651858.CD012565.pub2, lire en ligne, consulté le )
(en) Kamalita Pertiwi, Leanne K. Küpers, Janette de Goede et Peter L. Zock, « Dietary and Circulating Long-Chain Omega-3 Polyunsaturated Fatty Acids and Mortality Risk After Myocardial Infarction: A Long-Term Follow-Up of the Alpha Omega Cohort », Journal of the American Heart Association, vol. 10, no 23, , e022617 (ISSN2047-9980, PMID34845924, PMCID9075367, DOI10.1161/JAHA.121.022617, lire en ligne, consulté le )
(en) Ford ES, Caspersen CJ, « Sedentary behaviour and cardiovascular disease: a review of prospective studies », Int J Epidemiol, vol. 41, no 5, , p. 1338-53. (PMID22634869, DOI10.1093/ije/dys078, lire en ligne [html])modifier
« Pour les médecins, les hommes font des crises cardiaques, les femmes des crises d'angoisse », Slate.fr, (lire en ligne, consulté le )
thelancet.com
(en) Kivimäki M, Nyberg ST, Batty GD, Fransson EI, Theorell T et al. IPD-Work Consortium, « Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data », Lancet, vol. 380, no 9852, , p. 1491-7. (PMID22981903, PMCIDPMC3486012, DOI10.1016/S0140-6736(12)60994-5., lire en ligne [html])modifier
L. Acouetey, B. Diatta, I. Diouf et M. Seck, « Profil des patients admis pour infarctus du myocarde au service d'accueil des urgences de l'hopital principal de Dakar », Médecine Tropicale, vol. 67, no 6, , p. 569–572 (lire en ligne [PDF], consulté le ).
(en) Kivimäki M, Nyberg ST, Batty GD, Fransson EI, Theorell T et al. IPD-Work Consortium, « Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data », Lancet, vol. 380, no 9852, , p. 1491-7. (PMID22981903, PMCIDPMC3486012, DOI10.1016/S0140-6736(12)60994-5., lire en ligne [html])modifier
(en) Ford ES, Caspersen CJ, « Sedentary behaviour and cardiovascular disease: a review of prospective studies », Int J Epidemiol, vol. 41, no 5, , p. 1338-53. (PMID22634869, DOI10.1093/ije/dys078, lire en ligne [html])modifier